Benefit of TTR-stabilizer starts as early as 3 months in transthyretin amyloid cardiomyopathy3' education - Nov. 15, 2023 - Ahmad Masri, MD - Portland, OR, US
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, US.
Ahmad Masri is a cardiologist at OHSU Center for Hypertrophic Cardiomyopathy and Amyloidosis in Portland, OR, US.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.